XLONNSCI
Market cap15mUSD
Oct 21, Last price
52.50GBP
Name
Netscientific PLC
Chart & Performance
Profile
NetScientific plc is a venture capital firm specializing in seed, early and mid stage investments. The firm focuses to invest in sustainability, technology, transformative biomedical and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. NetScientific plc was founded in 2008 and is based in London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,445 43.92% | 1,004 -9.30% | 1,107 180.96% | |||||||
Cost of revenue | 5,659 | 5,504 | 4,136 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (4,214) | (4,500) | (3,029) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 3,138 | (37) | (61) | |||||||
Tax Rate | ||||||||||
NOPAT | (7,352) | (4,463) | (2,968) | |||||||
Net income | (2,643) -14.58% | (3,094) 29.73% | (2,385) 48.04% | |||||||
Dividends | (113,899) | |||||||||
Dividend yield | 807.21% | |||||||||
Proceeds from repurchase of equity | 21 | 1,502 | 7,309 | |||||||
BB yield | -0.15% | -8.38% | -40.90% | |||||||
Debt | ||||||||||
Debt current | 770 | 267 | 91 | |||||||
Long-term debt | 1,889 | 987 | 563 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 268 | 131 | ||||||||
Net debt | (15,662) | (23,034) | (15,034) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (3,141) | (3,106) | (3,480) | |||||||
CAPEX | (366) | (53) | (62) | |||||||
Cash from investing activities | 1,112 | (531) | (3,458) | |||||||
Cash from financing activities | 1,389 | 1,740 | 8,019 | |||||||
FCF | (532,959) | (3,726) | (3,081) | |||||||
Balance | ||||||||||
Cash | 365 | 852 | 2,710 | |||||||
Long term investments | 17,956 | 23,436 | 12,978 | |||||||
Excess cash | 18,249 | 24,238 | 15,633 | |||||||
Stockholders' equity | (57,105) | (48,933) | (54,283) | |||||||
Invested Capital | 602,866 | 75,429 | 73,446 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 23,517 | 22,267 | 18,051 | |||||||
Price | 0.60 -25.47% | 0.81 -18.69% | 0.99 112.90% | |||||||
Market cap | 14,110 -21.28% | 17,925 0.30% | 17,870 157.64% | |||||||
EV | (2,272) | (5,707) | 2,845 | |||||||
EBITDA | (3,752) | (4,153) | (2,781) | |||||||
EV/EBITDA | 0.61 | 1.37 | ||||||||
Interest | 171 | 55 | 22 | |||||||
Interest/NOPBT |